Symptomatic and preventive effects of the novel phosphodiesterase-9 inhibitor BI 409306 in an immune-mediated model of neurodevelopmental disorders.

Neuropsychopharmacology · 2021 · PMC8209175 · PMID 33941860

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

showed a trendP = 0.09so close (0.05 < p ≤ 0.1)

failed to reach statistical significanceno p-value reported

Comparison between CON and MIA groups using one-way RM-ANOVA failed to reach statistical significance, although BI 409306 treatment showed a trend for attenuation of distance moved following Amph treatment (main effect of groups; F [4,40] = 2.1; P = 0.09; Fig. 1C ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.